Shyam Srinivasan
Stock Analyst at Goldman Sachs
(0.26)
# 4,432
Out of 4,634 analysts
83
Total ratings
46.2%
Success rate
-11.4%
Average return
Main Sectors:
Stocks Rated by Shyam Srinivasan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: DIVISLAB Divi's Laboratories Limited | Upgraded: Buy | ₹6,375 → ₹8,035 | ₹8,300 | -3.19% | 6 | May 29, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Downgraded: Sell | ₹1,200 → ₹1,075 | ₹1,159 | -7.23% | 6 | Apr 23, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹7,850 → ₹8,550 | ₹8,912 | -4.06% | 2 | Dec 7, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Downgraded: Hold | ₹700.00 → ₹965.00 | ₹945.15 | +2.10% | 2 | Dec 7, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Initiated Coverage: Buy | ₹900.00 | ₹819.50 | +9.82% | 1 | Dec 7, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Initiated Coverage: Buy | ₹1,325 | ₹1,069 | +23.95% | 1 | Dec 7, 2025 | |
| NSE: ICICIPRULI ICICI Prudential Life Insurance Company Limited | Maintained: Hold | ₹625.00 → ₹650.00 | ₹497.25 | +30.72% | 3 | Oct 15, 2025 | |
| NSE: LAURUSLABS Laurus Labs Limited | Maintained: Sell | ₹675.00 → ₹750.00 | ₹1,854 | -59.55% | 8 | Oct 14, 2025 | |
| NSE: NEULANDLAB Neuland Laboratories Limited | Maintained: Buy | ₹15,750 → ₹17,225 | ₹22,216 | -22.47% | 5 | Oct 14, 2025 | |
| NSE: BIOCON Biocon Limited | Maintained: Hold | ₹345.00 → ₹335.00 | ₹426.10 | n/a | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹800.00 → ₹775.00 | ₹402.60 | n/a | 5 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,300 → ₹1,250 | ₹1,648 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,375 → ₹1,350 | ₹1,468 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,435 → ₹1,525 | ₹2,667 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,975 | ₹2,300 | n/a | 4 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹265.00 → ₹250.00 | ₹214.29 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹830.00 → ₹890.00 | ₹540.00 | n/a | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹465.00 | ₹393.00 | n/a | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,860 → ₹2,015 | ₹1,855 | n/a | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,650 → ₹1,680 | ₹2,021 | n/a | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,325 | ₹1,954 | n/a | 1 | Apr 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,475 → ₹1,500 | ₹1,944 | n/a | 4 | Apr 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,350 | ₹447.00 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,675 | ₹572.65 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,975 | ₹1,649 | n/a | 1 | Jan 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.875 | n/a | 1 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $12.15 | n/a | 1 | May 2, 2016 |
Divi's Laboratories Limited
May 29, 2026
Upgraded: Buy
Price Target: ₹6,375 → ₹8,035
Current: ₹8,300
Upside: -3.19%
Dr. Reddy's Laboratories Limited
Apr 23, 2026
Downgraded: Sell
Price Target: ₹1,200 → ₹1,075
Current: ₹1,159
Upside: -7.23%
Apollo Hospitals Enterprise Limited
Dec 7, 2025
Maintained: Buy
Price Target: ₹7,850 → ₹8,550
Current: ₹8,912
Upside: -4.06%
Fortis Healthcare Limited
Dec 7, 2025
Downgraded: Hold
Price Target: ₹700.00 → ₹965.00
Current: ₹945.15
Upside: +2.10%
Krishna Institute of Medical Sciences Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹900.00
Current: ₹819.50
Upside: +9.82%
Max Healthcare Institute Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹1,325
Current: ₹1,069
Upside: +23.95%
ICICI Prudential Life Insurance Company Limited
Oct 15, 2025
Maintained: Hold
Price Target: ₹625.00 → ₹650.00
Current: ₹497.25
Upside: +30.72%
Laurus Labs Limited
Oct 14, 2025
Maintained: Sell
Price Target: ₹675.00 → ₹750.00
Current: ₹1,854
Upside: -59.55%
Neuland Laboratories Limited
Oct 14, 2025
Maintained: Buy
Price Target: ₹15,750 → ₹17,225
Current: ₹22,216
Upside: -22.47%
Biocon Limited
Aug 8, 2025
Maintained: Hold
Price Target: ₹345.00 → ₹335.00
Current: ₹426.10
Upside: n/a
Jul 24, 2025
Maintained: Buy
Price Target: ₹800.00 → ₹775.00
Current: ₹402.60
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: ₹1,300 → ₹1,250
Current: ₹1,648
Upside: n/a
Jul 15, 2025
Maintained: Sell
Price Target: ₹1,375 → ₹1,350
Current: ₹1,468
Upside: n/a
Jul 15, 2025
Maintained: Sell
Price Target: ₹1,435 → ₹1,525
Current: ₹2,667
Upside: n/a
Jul 15, 2025
Maintained: Hold
Price Target: ₹1,975
Current: ₹2,300
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: ₹265.00 → ₹250.00
Current: ₹214.29
Upside: n/a
Jul 8, 2025
Maintained: Buy
Price Target: ₹830.00 → ₹890.00
Current: ₹540.00
Upside: n/a
Jul 8, 2025
Maintained: Hold
Price Target: ₹465.00
Current: ₹393.00
Upside: n/a
Jul 8, 2025
Maintained: Buy
Price Target: ₹1,860 → ₹2,015
Current: ₹1,855
Upside: n/a
May 2, 2025
Maintained: Sell
Price Target: ₹1,650 → ₹1,680
Current: ₹2,021
Upside: n/a
Apr 26, 2025
Maintained: Sell
Price Target: ₹1,325
Current: ₹1,954
Upside: n/a
Apr 18, 2025
Maintained: Sell
Price Target: ₹1,475 → ₹1,500
Current: ₹1,944
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: ₹1,350
Current: ₹447.00
Upside: n/a
Feb 6, 2025
Maintained: Sell
Price Target: ₹1,675
Current: ₹572.65
Upside: n/a
Jan 19, 2025
Maintained: Hold
Price Target: ₹1,975
Current: ₹1,649
Upside: n/a
Jul 26, 2021
Maintained: Hold
Price Target: n/a
Current: $0.875
Upside: n/a
May 2, 2016
Initiated Coverage: Hold
Price Target: n/a
Current: $12.15
Upside: n/a